2O'Brien PJ, Alborn WE, Sloan J H,et al. The novel apolipoprotein A5 is present in human serum,is associated with VLDL, HDL, and chylomi-crons,and circulates at very low concentrations com- pared with other apolipoproteins[J]. Clin Chem, 2007,51 (2) : 351- 359.
3Prieur X. The human apolipoprote in AV gene is regulated by peroxisome proliferator-activated receptor alpha and contains a novel farnesoid X-activated receptor response element[J]. J Biol Chem, 2006,278(28):25468- 25480.
4Vu-Dac N, Gervois P, Jakel H, et al. ApolipoprotelnA5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators[J]. J Biol Chem,2006,278(20) : 17982-17985.
5Lind U, Nilsson T, Mc Pheat J, et al. Identification of the human ApoAVgene as a novel RORalpha target gene[J]. Biochem Biophys Res Commun,2007,330(1) :233-241.
6Genoux A, Dehondt H, Helleboid-Chapman A, et al. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptorRORalpha[J]. Arterioscler Thromb Vase Bio,2006, 25(6) : 1186-1192.
7Jakel H, Nowak M, Moitrot E,et al. The liver X receptor Iigand T0901317 clown regulates ApoA5 gene expression through activation of SREBP-lc[J]. J Biol Chem,2006,279(44);45462-45469.
8Merkel M, Loeffler B,Kluger M. Apolipoprote in A-V accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteogly can-bound lipoprotein lipase [J]. J Biol Chem, 2007,280(22) :21553- 21560.
9Schaap FG, Rensen PC, Voshol PJ, et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL TG hydrolys is[J]. J Biol Chem,2006,279(27):27941- 27947.
二级参考文献10
1Pennacchio LA,Olivier M,Hubacek JA,et al.An Apolipoprotein influencing TG in humans and mice revealed by comparative sequencing[J].Science,2001,294:169-173.
2Vn der Vliet HN,Schaap FG,Levels JH,et al.Adenoviral overexpression of apolipoprotein AV reduces serum levels of triglycerides and cholesterol in mice[J].Biochem Biophys Res Commun,2002,295:1156-1159.
3Pennacchio LA,Rubin EM.Apolipoprotein A5,a newly identified gene that affects plasma triglyceride levels in humans and mice review[J].Arterioscler Thromb Vasc Biol,2003,23:529-534.
4Beckstead JA,Oda MN,Martin DD,et al.Structure-function studies of human apolipoprotein A-V:a regulator of plasma lipid homostasis[J].Biochemistry,2003,42:9416-9423.
5Weinberg RB,Cook VR,Berkstead JA,et al.Structure and interfacial properties of human apolipoprotein A-V[J].J Biol Chem,2003,278:34438-34444.
6Talmud PJ,Hawe E,Martin S,et al.Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides[J].Hum Mol Genet,2002,11:3039-3046.
7Baroukh N,Bauge E,Akiyama J,et al.Analysis of apolipoprotein A5,C3,and plasma triglyceride concentrations in genetically engineered mice[J].Arterioscler Thromb Vasc Biol,2004,7:1297-1302.
8Van der Vliet HN,Sammels MG,Leegwater AC,et al.Apolipoprotein AV:A novel apolipoprotein associated with an early phase of liver regeneration[J].J Biol Chem,2001,276:44512-44520.
9Ishihara M,Kujiraoka T,Iwasaki T,et al.A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration[J].Journal of Lipid Research,2005,46:2015-2022.
10O'Brien PJ,Alborn WE,Sloan JH,et al.The novel apolipoprotein A5 is present in human serum,is associated with VLDL,HDL,and chylomicrons,and circulates at very low concentrations compared with other apolipoproteins[J].Clin Chem,2005,51:351-359.
